Iron pills boost blood donations in ghana trial
NCT ID NCT06101238
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether giving low-dose iron supplements (65 mg daily) for 6 months helps people with low hemoglobin pass the blood donation screening and successfully donate within a year. Over 500 adults in Ghana who were deferred from donating due to low hemoglobin took part. Half received iron plus nutrition advice; the other half got nutrition advice only. Researchers tracked successful donations and side effects for 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
low-dose elemental iron (65 mg daily)
What this could lead to
If successful, this could help blood banks increase safe donations by quickly restoring hemoglobin levels in deferred donors.
What could go wrong
This is a completed pragmatic trial in Ghana; results may not apply to other settings. Iron supplements can cause mild stomach upset.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD DONATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55414, United States